title: Gastrointestinal dysfunction following hemolytic uremic syndrome.
authors.affiliation: Princeton University, Princeton, NJ, USA. cbowles@princeton.edu
authors.forename: Cayley
authors.initials: C
authors.lastname: Bowles
authors.forename: Megan
authors.initials: M
authors.lastname: Ancker
authors.forename: George
authors.initials: G
authors.lastname: Triadafilopoulos
mesh_terms: D015746:Abdominal Pain / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D000293:Adolescent; D000700:Analgesics / Q000627:therapeutic use; D001285:Atropine / Q000627:therapeutic use; D001464:Barium; D002648:Child; D004927:Escherichia coli Infections / Q000175:diagnosis / Q000503:physiopathology; D019453:Escherichia coli O157 / Q000302:isolation & purification; D005260:Female; D005767:Gastrointestinal Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D006463:Hemolytic-Uremic Syndrome / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D006801:Humans; D008276:Magnesium Hydroxide; D008899:Mineral Oil / Q000627:therapeutic use; D010098:Oxycodone / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011813:Quinuclidinyl Benzilate / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000700:Analgesics; D001464:Barium; D011092:Polyethylene Glycols; D011813:Quinuclidinyl Benzilate; D001285:Atropine; D008899:Mineral Oil; C054940:clidinium; D010098:Oxycodone; D008276:Magnesium Hydroxide